Financial Performance - The company's revenue for Q3 2022 reached ¥1,326,633,392.21, representing a 45.99% increase year-over-year[6] - Net profit attributable to shareholders was ¥160,746,353.26, up 41.72% compared to the same period last year[6] - The net profit after deducting non-recurring gains and losses was ¥157,069,097.47, reflecting a 48.76% increase year-over-year[6] - The company's revenue from sales of goods and services reached ¥2,735,669,441.66, an increase of 58.11% compared to the previous period[12] - Net profit for Q3 2022 was CNY 438,905,159.95, representing a 42.6% increase from CNY 307,683,631.06 in Q3 2021[27] - Total operating revenue for Q3 2022 reached CNY 3,594,343,098.16, a significant increase of 42.4% compared to CNY 2,525,413,022.81 in the same period last year[25] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥7,484,616,392.66, a 34.19% increase from the end of the previous year[6] - The total assets as of September 30, 2022, were CNY 38.36 billion, with a notable increase in financial assets from previous periods[19] - Current liabilities increased to CNY 2,744,987,309.46, up 27% from CNY 2,163,736,758.99 year-over-year[24] - The total liabilities of the company reached CNY 3,644,685,223.64, an increase of 23.4% from CNY 2,951,610,333.29 year-over-year[24] Shareholder Information - The equity attributable to shareholders increased to ¥3,729,272,495.71, marking a 47.94% rise compared to the previous year[6] - The equity attributable to shareholders of the parent company was CNY 3,729,272,495.71, up from CNY 2,520,831,367.36 in the previous year, indicating a growth of 47.8%[24] - The number of ordinary shareholders at the end of the reporting period was 10,123[13] - The largest shareholder, Tianjin Lianlong Technology Group Co., Ltd., holds 14.14% of the shares, totaling 32,461,290 shares[13] Cash Flow - Cash flow from operating activities for the year-to-date was ¥334,160,084.84, showing a significant increase of 125.43%[6] - Cash inflow from operating activities reached CNY 3,228,626,177.81, compared to CNY 1,829,937,461.01 in the previous period, reflecting a significant increase[30] - Cash received from tax refunds was ¥175,290,226.18, up 180.66% due to increased export tax rebates[12] - Cash outflow from investing activities totaled CNY 370,524,595.17, a decrease from CNY 420,941,205.74 in the previous period[32] Expenses - Research and development expenses increased by 43.40% to ¥158,009,805.40, indicating a commitment to innovation[10] - Operating costs for the same period were CNY 3,092,258,388.11, up 41.3% from CNY 2,189,010,889.98 year-over-year[25] - Tax expenses amounted to ¥69,729,331.91, reflecting a 65.70% increase due to higher profits[12] - The company reported a financial expense of CNY 41,719,682.51, which increased from CNY 29,866,922.28 in the previous year[27] Strategic Initiatives - The company plans to continue expanding its market presence and developing new products and technologies[12] - The company is actively pursuing market expansion strategies, including potential mergers and acquisitions to enhance its competitive position[18] - The company is focusing on new product development and technological advancements to drive future growth and market share[18] - The company is committed to maintaining a robust financial position while exploring innovative strategies for sustainable growth[18] Investment and Financing - The company invested ¥180,044,950.40 in cash, an increase of 814.84%, primarily due to the acquisition of Kangtai[12] - The company has seen a significant increase in cash paid for financing activities, with payments rising by 369.57% to ¥179,375,678.00[12] - The total amount raised through private placements for asset purchases was CNY 30.24 billion, showcasing strong investor confidence[19] Other Financial Metrics - Basic and diluted earnings per share were both CNY 2.0248, up from CNY 1.4621 in the previous period[29] - The total comprehensive income for the period amounted to CNY 455,977,663.77, an increase of 303,831,382.46 compared to the previous period[29] - The ending balance of cash and cash equivalents was CNY 516,937,155.13, compared to CNY 334,422,991.18 at the end of the previous period[32] - The report for the third quarter was not audited[33]

Financial Performance - The company reported a revenue of 300 million RMB for the first half of 2022, representing a 15% increase compared to the same period in 2021[2]. - The company's revenue for the first half of 2022 reached CNY 2,267,709,705.95, representing a 40.27% increase compared to CNY 1,616,724,522.10 in the same period last year[25]. - Net profit attributable to shareholders was CNY 274,360,182.19, up 47.25% from CNY 186,323,810.43 year-on-year[25]. - The net cash flow from operating activities surged by 324.81%, amounting to CNY 133,190,907.00 compared to CNY 31,352,933.12 in the previous year[25]. - Basic and diluted earnings per share increased by 45.46% to CNY 1.3221 from CNY 0.9089[25]. - The company achieved a revenue of ¥2,267,709,705.95, representing a 40.27% increase year-over-year, and a net profit of ¥274,360,182.19, up 47.25% from the previous year[77]. - The company has maintained a compound annual growth rate of 29.39% in revenue over the past eleven years, demonstrating consistent business growth despite external challenges[77]. Market Expansion and Product Development - The company plans to launch two new products in Q3 2022, aiming to capture a larger market share in the new materials sector[2]. - Future outlook includes a projected revenue growth of 25% for the full year 2022, driven by increased demand and market expansion efforts[2]. - The company is exploring potential acquisitions to enhance its product offerings and market presence, with a focus on companies in the new materials industry[2]. - The company is actively involved in the production and sales of various chemical products, with a focus on expanding its market presence in the new materials sector[121]. - The company has established a dual-base production strategy, ensuring stable supply across all product lines by having two production bases for each product, enhancing supply chain resilience[196]. Research and Development - Research and development expenses increased by 10% to 30 million RMB, reflecting the company's commitment to innovation and new technology development[2]. - The company has invested in enhancing its R&D capabilities, aiming to build a first-class lubricant additive research center in China[61]. - The company has formed partnerships with leading universities and research institutions to enhance its R&D capabilities in the nucleic acid drug sector, establishing a foundation for its third growth curve[56]. - The company plans to continue its research and development in new materials technology, aiming to enhance its product offerings and market competitiveness[121]. Acquisitions and Investments - The company completed the acquisition of Jinzhou Kangtai, expanding its business into lubricant additives during a critical period for supply chain autonomy[44]. - The company acquired a 99.82% stake in Jinzhou Kangtai Lubricant Additive Co., Ltd. for ¥639,672,429.93, funded through share issuance and raised capital[99]. - The company completed the acquisition of Jinzhou Kangtai, which generated a revenue of ¥117,649,636.69 in May-June, marking a 50.80% increase year-over-year, and a net profit of ¥15,802,333.76, up 71.69%[80]. Risk Management - The company has identified key risks including raw material price fluctuations and market competition, and is implementing strategies to mitigate these risks[2]. - The company faces risks from raw material price fluctuations, which are influenced by international crude oil prices and market supply conditions, impacting production costs[127]. - The company has implemented measures to mitigate risks from raw material price volatility, including establishing long-term supplier relationships and enhancing brand influence to improve bargaining power[129]. - The company has outlined strategies to manage risks associated with accounts receivable, including performance assessments for sales personnel and legal measures for debt collection[131]. Environmental Compliance and Sustainability - The company emphasizes environmental protection and safety production, adhering to EHS management systems to prevent potential accidents and ensure compliance with evolving regulations[130]. - The company has implemented various environmental protection measures, including wastewater treatment that meets standards, with a total wastewater discharge of 48,262 tons and COD emissions of 11.535 tons[155]. - The company has established a comprehensive environmental management system, ensuring that all production bases have effective wastewater and air pollution control facilities in normal operation[179]. - The company has committed to using clean energy sources, such as natural gas, for its boiler operations, contributing to reduced emissions[177]. - The company achieved a total reduction of 922 tons of CO2 in the first half of 2022 through various initiatives[190]. Corporate Governance and Shareholder Engagement - The company reported a participation rate of 42.88% in the 2021 annual general meeting held on March 21, 2022[144]. - The first extraordinary general meeting of 2022 had a participation rate of 36.34% on May 13, 2022[144]. - The company did not distribute cash dividends or bonus shares for the half-year period[148]. - The company appointed new executives on July 13, 2022, including a new chairman and president[146]. - The company held multiple investor communication sessions discussing business models and future development plans[138]. Employee Welfare and Social Responsibility - The company has implemented a comprehensive employee welfare system, including health check-ups and various recreational activities, to enhance employee satisfaction and retention[198]. - The company actively participates in social responsibility initiatives and has received recognition for its contributions to community welfare[200].

Revenue and Profitability - Revenue for Q1 2022 reached ¥1,010,659,817.18, an increase of 23.04% compared to ¥821,422,925.46 in the same period last year[4] - Net profit attributable to shareholders was ¥126,246,491.44, up 39.66% from ¥90,396,947.81 year-on-year[4] - Net profit excluding non-recurring gains and losses was ¥125,466,715.11, reflecting a 43.82% increase from ¥87,237,737.08 in the previous year[4] - Basic earnings per share rose to ¥0.6158, a 39.67% increase compared to ¥0.4409 in the same period last year[4] - Net profit for the quarter was ¥125,218,058.20, a significant increase of 36.73% from ¥91,602,078.29 in the same period last year[32] - The net profit attributable to the parent company was approximately ¥126.25 million, compared to ¥90.40 million in the previous period, representing an increase of 39.7%[35] - The total comprehensive income attributable to the parent company was approximately ¥125.09 million, up from ¥88.98 million, reflecting a growth of 40.5%[35] - Basic and diluted earnings per share both increased to ¥0.6158 from ¥0.4409, marking a rise of 39.5%[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,924,630,711.53, representing a 6.22% increase from ¥5,577,662,386.18 at the end of the previous year[4] - Total liabilities rose to ¥3,173,409,175.15, compared to ¥2,951,610,333.29, indicating an increase of 7.49%[27] - The company's total assets increased to ¥5,924,630,711.53, up from ¥5,577,662,386.18, marking a growth of 6.21%[27] - Short-term borrowings increased to ¥719,175,765.98 from ¥656,245,603.47, representing a rise of 9.06%[27] - The company reported a significant increase in accounts payable, which rose to ¥431,004,701.98 from ¥398,009,791.54, an increase of 8.29%[27] Cash Flow - Cash flow from operating activities decreased by 18.07% to ¥37,360,730.31 from ¥45,599,776.45 in the previous year[4] - Cash inflows from operating activities totaled approximately ¥791.55 million, compared to ¥617.29 million in the previous period, indicating a growth of 28.2%[39] - Cash outflows from operating activities amounted to approximately ¥754.19 million, up from ¥571.69 million, representing an increase of 31.9%[39] - The net cash flow from operating activities was approximately ¥37.36 million, down from ¥45.60 million, showing a decrease of 18.5%[39] - Net cash flow from investing activities was approximately -¥96.68 million, compared to -¥127.87 million in the previous period, indicating an improvement of 24.4%[42] - Net cash flow from financing activities was approximately ¥47.92 million, down from ¥104.76 million, reflecting a decrease of 54.3%[42] - The ending balance of cash and cash equivalents was approximately ¥387.05 million, compared to ¥195.87 million in the previous period, showing an increase of 97.5%[42] - The company reported a tax refund of approximately ¥23.20 million, compared to ¥17.06 million in the previous period, representing a growth of 36.1%[39] Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,488, with the top ten shareholders holding a combined 45.64% of shares[13] - Tianjin Lianlong Technology Group Co., Ltd. holds 15.83% of shares, while Lianlong International Group Co., Ltd. holds 12.22%[13] - The company has a pledge of 5,760,000 shares by Tianjin Lianlong Technology Group Co., Ltd.[13] Inventory and Receivables - Accounts receivable increased to CNY 640.74 million from CNY 576.16 million, reflecting a growth of approximately 11.2%[21] - Inventory levels rose significantly to CNY 1.02 billion, up from CNY 893.07 million, indicating a growth of around 14.6%[21] - The company experienced a 39.55% decrease in receivables financing, with a balance of ¥16,308,013.61 compared to ¥26,978,590.89 at the beginning of the period[8] Other Income and Expenses - Other income decreased by 42.38% to ¥2,169,817.36, down from ¥3,765,940.30 due to reduced government subsidies[12] - Research and development expenses totaled ¥40,033,425.12, which is an increase of 17.92% compared to ¥33,954,645.86 from the previous year[32] Acquisition Plans - The company plans to acquire 92.21% of Jinzhou Kangtai Lubricant Additive Co., Ltd. through a combination of stock issuance and cash payment[18] - The company intends to raise supporting funds by issuing shares to no more than 35 specific investors[18] Restricted Shares - The total number of restricted shares at the beginning of the period was 19,383,076, with 5,627,345 shares released during the period[17]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a 15% increase compared to RMB 1.04 billion in 2020[19]. - The net profit for 2021 was RMB 150 million, which is a 20% increase from RMB 125 million in the previous year[19]. - The company's operating revenue for 2021 was ¥3,444,636,127.78, representing a 38.74% increase compared to ¥2,482,787,134.26 in 2020[30]. - The net profit attributable to shareholders for 2021 was ¥417,594,673.31, up 42.53% from ¥292,993,191.27 in 2020[30]. - The net cash flow from operating activities increased by 66.93% to ¥312,125,695.41 in 2021, compared to ¥186,979,247.25 in 2020[30]. - The company achieved an operating revenue of CNY 3,444,636,127.78, representing a year-on-year growth of 38.74%[130]. - Net profit attributable to shareholders reached CNY 417,594,673.31, an increase of 42.53% compared to the previous year[130]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 3.06 yuan (including tax) for every 10 shares, with no bonus shares issued[6]. Market and Growth Projections - The company has set a revenue guidance of RMB 1.5 billion for 2022, indicating a projected growth of 25% year-over-year[19]. - The company aims to achieve sales revenue of 5 billion yuan by 2023 and 10 billion yuan by 2028 as part of its 2.0 strategic goal[88]. - The global market for lubricating oil additives reached $15.1 billion in 2019 and is projected to grow to $18.5 billion by 2023, with China's demand accounting for over 20% of the global market[54]. - The domestic lubricating oil additives market is estimated to reach $3.8 billion, indicating significant growth potential[54]. Research and Development - The company is investing RMB 200 million in R&D for new chemical additives and stabilizers in 2022[19]. - The company has built a research team of over 150 members and has been recognized as a national-level enterprise technology center, enhancing its innovation capabilities[94]. - R&D expenses rose by 48.93% to ¥151,302,828.98 in 2021, reflecting increased investment in R&D[159]. - R&D investment accounted for 4.39% of operating revenue in 2021, up from 4.09% in 2020[164]. Product Development and Innovation - New product launches in 2021 included the U-pack, which contributed to a 30% increase in sales of polymer materials[19]. - The company has developed a comprehensive product line in polymer material aging resistance, including primary and secondary antioxidants, UV absorbers, and custom blends[68]. - The company has developed various production technologies for antioxidants and light stabilizers, including high-performance UV absorbers and multifunctional antioxidants[100]. Market Expansion and Customer Base - User data showed a growth in customer base by 25%, reaching 500,000 active users by the end of 2021[19]. - Market expansion efforts have led to a 40% increase in exports, with significant growth in Southeast Asia and Europe[19]. - The company has established a significant market presence in China, with exports to over 20 countries, primarily in the Asia-Pacific region[64]. Operational Efficiency and Cost Management - The company aims to achieve a 15% reduction in production costs through improved EHS management practices by the end of 2022[19]. - The average price of major raw materials increased significantly, with the average cost per ton rising by approximately 2400 yuan due to fluctuations in prices of fatty acids and esters, aromatic amines, inorganic compounds, and aliphatic hydrocarbons[92]. - The company has established a "backup production line" model with two independent production lines for each product to ensure stable supply as the primary supplier for global major clients[83]. Strategic Partnerships and Collaborations - The company has formed partnerships with several universities to foster innovation and develop new products in aging resistance technology[73]. - The company has established long-term partnerships with universities for R&D and talent cultivation, enhancing its innovation capabilities[98]. Environmental and Regulatory Compliance - The company has received environmental impact approvals for several projects, including technology upgrades and wastewater treatment facilities[109]. - The company is committed to maintaining high standards in product quality and environmental sustainability through advanced production techniques[100]. - The company is committed to compliance with regulatory requirements, ensuring all operations are approved by relevant authorities[180]. Challenges and Risks - The company emphasizes risks related to market environment, raw material price fluctuations, environmental protection, accounts receivable, talent reserves, new projects, and mergers and acquisitions[6]. - The company reported a net loss of 4,059,532.14 yuan, indicating challenges in profitability[183]. Investment and Financial Strategy - The company invested a total of CNY 896,172,553.37 in various projects during the reporting period, with a cumulative actual investment of CNY 1,355,492,791.84[186]. - The total investment amount for the reporting period was ¥1.03 billion, a 178.77% increase compared to ¥370.09 million in the same period last year[174].

Financial Performance - The company's operating revenue for Q3 2021 was CNY 908,688,500.71, representing a 51.90% increase year-over-year[5] - The net profit attributable to shareholders for the same period was CNY 113,429,064.83, up 44.71% compared to the previous year[5] - The net profit after deducting non-recurring gains and losses reached CNY 105,587,981.72, reflecting a 41.40% increase year-over-year[5] - The basic earnings per share for Q3 2021 was CNY 0.5533, an increase of 44.73% from the same period last year[5] - Operating revenue increased by 45.30% to CNY 2,525,413,022.81, driven by higher sales volume[12] - Net profit for the period was ¥307,683,631.06, representing a 43.9% increase compared to ¥213,809,574.90 in the same period last year[39] - Total operating revenue for the period reached ¥2,525,413,022.81, a 45.4% increase from ¥1,738,123,215.76 in the previous period[36] - Total comprehensive income for the period was ¥303,831,382.46, up from ¥212,170,880.48, reflecting overall growth in financial performance[39] Assets and Liabilities - Total assets at the end of Q3 2021 amounted to CNY 5,091,511,322.89, a 33.52% increase from the end of the previous year[5] - The total assets of the company reached RMB 5,091,511,322.89, a significant increase from RMB 3,813,249,520.04, marking a growth of 33.6%[28] - The company's total equity attributable to shareholders increased to CNY 2,407,011,693.12, a rise of 11.67% from the previous year[5] - The total liabilities increased to ¥2,587,883,636.97, up from ¥1,633,086,589.43, indicating a significant rise in financial obligations[36] - Non-current liabilities totaled ¥727,025,996.92, compared to ¥408,142,561.94 in the previous period, showing a 78.1% increase[36] Cash Flow - The company's cash flow from operating activities for the year-to-date was CNY 148,231,926.49, showing a significant increase of 132.35%[5] - Cash received from operating activities increased by 41.13% to CNY 1,730,245,459.86, reflecting revenue growth[12] - Operating cash flow for the current period reached ¥148,231,926.49, a significant increase of 132.2% compared to ¥63,795,711.71 in the previous period[43] - Cash inflow from operating activities totaled ¥1,829,937,461.01, up from ¥1,299,294,257.04, reflecting a growth of 40.9%[43] Inventory and Borrowings - The company reported a significant increase in inventory, which reached CNY 777,238,976.86, a 42.43% increase due to higher sales volume[9] - Short-term borrowings increased by 65.63% to CNY 645,645,114.25, primarily to meet the increased working capital needs[9] - Long-term borrowings increased by 86.35% to CNY 681,527,958.95, reflecting higher bank financing to meet project funding needs[12] Equity and Investments - The company's total equity reached ¥2,503,627,685.92, up from ¥2,180,162,930.61, indicating a growth of 14.8%[36] - The company completed a capital increase subscription for Inner Mongolia Unik Materials Technology Co., which has been renamed to Lianlong (Inner Mongolia) New Materials Co., establishing a second production base for its HALS product line[21] - The company is in the process of acquiring 92.2109% equity of Jinjou Kangtai Lubricant Additive Co., which is pending regulatory approval[24] Research and Development - Research and development expenses for the period were ¥110,186,939.55, an increase from ¥88,784,591.07, highlighting a focus on innovation[36] Other Financial Metrics - The weighted average return on equity was 4.83%, up 26.11% compared to the previous year[5] - The company reported a decrease in other comprehensive income, with a net amount of -¥3,852,248.60 compared to -¥1,638,694.42 in the previous period[39] - The company has not undergone an audit for the third quarter report[57] - The report indicates that the company has implemented new leasing standards starting from 2021[57]

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2021, representing a 20% increase compared to the same period in 2020[26]. - The gross profit margin improved to 35% in the first half of 2021, up from 30% in the previous year[26]. - The company's operating revenue for the reporting period was ¥1,616,724,522.10, representing a 41.83% increase compared to ¥1,139,897,217.37 in the same period last year[39]. - The net profit attributable to shareholders was ¥186,323,810.43, up 38.07% from ¥134,949,059.83 year-on-year[39]. - The net profit after deducting non-recurring gains and losses was ¥179,328,278.55, reflecting a 32.22% increase from ¥135,624,588.80 in the previous year[39]. - The company achieved a revenue of CNY 1,616,724,522.10, representing a year-on-year growth of 41.83%[96]. - The net profit attributable to shareholders was CNY 186,323,810.43, an increase of 38.07% compared to the same period last year[96]. Market Expansion and Growth Strategy - The company plans to expand its production capacity by 25% in the next year to meet growing demand[26]. - Market expansion efforts will focus on Southeast Asia, targeting a 10% market share by 2023[26]. - The company aims to achieve sales revenue of 5 billion yuan by 2023 and 10 billion yuan by 2028 as part of its 2.0 strategic goal[67]. - The company is exploring potential acquisitions to enhance its supply chain capabilities and reduce costs[26]. - The company is advancing the acquisition of lubricant additive companies to establish a second growth curve, with the global demand for lubricant additives projected to grow at a compound annual growth rate of 2.52% from 2020 to 2023[97]. - Lianlong is actively investing in R&D, with a budget allocation of 100 million RMB for the development of new products and technologies in 2021[199]. - The company plans to expand its market presence by entering two new regional markets by the end of 2021, aiming for a 10% market share in these areas[198]. Operational Challenges and Risks - The company reported a significant increase in raw material procurement costs and international logistics expenses, impacting production operations[5]. - The company is facing risks related to environmental and safety production, which could adversely affect its assets and employee safety[7]. - The company has a high proportion of accounts receivable, which poses a risk if major clients face operational difficulties[8]. - The company is facing risks related to the COVID-19 pandemic, which continues to affect global economic operations and may impact business performance[132]. - The company is closely monitoring macroeconomic changes and policy trends to manage foreign exchange risks effectively[136]. - The company is facing risks related to macroeconomic factors, including exchange rate fluctuations and international trade dynamics, which could impact performance[136]. - The company has initiated various measures to mitigate operational risks, including promoting sales and optimizing cash flow[132]. Research and Development - The company is investing RMB 50 million in R&D for new chemical additives aimed at improving product performance[26]. - The company has established partnerships with several universities for research and development of new products and technologies[54]. - The company has committed to ongoing investment in technology research and development to lower production costs and enhance competitiveness[136]. - Research and development investment reached ¥64,732,853.62, an increase of 19.56% year-on-year, indicating a commitment to innovation[105]. Environmental and Safety Compliance - The company emphasizes the importance of adapting to changes in safety and environmental regulations to avoid production disruptions[7]. - The company achieved a hazardous waste treatment compliance rate of 100%, with a total of 502,120 kg of hazardous waste processed[160]. - The company’s wastewater treatment met the Class III standard of the Comprehensive Discharge Standard for Wastewater (GB8978-1996)[160]. - The company has established a comprehensive environmental management system, ensuring that all production bases are equipped with effective wastewater and air pollution control facilities, which are currently operational[172]. - The company has committed to continuous improvement in environmental protection measures, including the modernization of facilities and adherence to "zero discharge" requirements for wastewater[180]. - The company has established a dedicated EHS management team responsible for compliance with environmental laws and regulations[172]. Corporate Governance and Shareholder Relations - The company will not distribute cash dividends or issue bonus shares, nor will it increase capital from reserves[10]. - The second phase of the employee stock ownership plan was approved, aiming to enhance corporate governance and employee cohesion, with a maximum funding scale of 200 million CNY[150]. - The company guarantees the authenticity, accuracy, and completeness of the information provided for the transaction, assuming legal responsibility for any false records or misleading statements[184]. - The company has committed to improving its compensation system to align with the dilution of immediate returns from the restructuring process[187]. - The company has confirmed that there are no ongoing or foreseeable major lawsuits or administrative penalties against it[187]. Strategic Partnerships and Collaborations - The company has initiated a strategic partnership with BASF to enhance its product offerings in the polymer materials sector[26]. - The company is actively participating in the establishment of a Chinese standard for engine lubricants, collaborating with major international and domestic companies in the lubricant additive sector[97]. - The company has established long-term partnerships with key suppliers to mitigate raw material price fluctuations, enhancing bargaining power and cost control[133]. Financial Management and Investment - The total investment during the reporting period was ¥349,718,676.72, representing a 70.27% increase compared to the previous year[115]. - Long-term loans increased by 35.34% to ¥494,960,241.01, primarily due to increased bank financing for project construction[109]. - The company's cash flow from investment activities saw a significant decrease of 84.14%, totaling ¥807,368.01[109]. - The company has no fundraising activities or derivative investments during the reporting period[120][121][122].

Financial Performance - The company's operating revenue for Q1 2021 was ¥821,422,925.46, representing a 45.94% increase compared to ¥562,866,375.94 in the same period last year[7]. - The net profit attributable to shareholders for Q1 2021 was ¥90,396,947.81, up 42.84% from ¥63,285,692.37 in the previous year[7]. - Basic earnings per share for Q1 2021 were ¥0.4409, a 42.82% increase from ¥0.3087 in the same quarter last year[7]. - The company achieved operating revenue of ¥821,422,925.46, a year-on-year increase of 45.94%[20]. - Net profit attributable to shareholders reached ¥90,396,947.81, up 42.84% compared to the same period last year[20]. - Total operating revenue for the current period reached ¥821,422,925.46, a significant increase from ¥562,866,375.94 in the previous period, representing a growth of approximately 46%[64]. - Net profit for the current period was ¥91,602,078.29, compared to ¥61,259,954.48 in the previous period, reflecting an increase of approximately 49%[70]. - Earnings per share (EPS) for the current period was ¥0.4409, up from ¥0.3087 in the previous period, marking an increase of about 43%[74]. - The company achieved a total comprehensive income of ¥90,179,747.65, up from ¥62,867,188.68, indicating an increase of approximately 43.6%[74]. Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 269.49%, reaching ¥45,599,776.45 compared to ¥12,341,394.12 in Q1 2020[7]. - Cash inflow from operating activities totaled ¥617,290,376.23, a 47.68% increase driven by expanded operations[20]. - The company reported a cash balance of approximately ¥225.88 million as of March 31, 2021, an increase from ¥191.47 million on December 31, 2020, reflecting a growth of about 17.9%[48]. - The cash and cash equivalents at the end of the period amount to CNY 195,865,070.40, down from CNY 364,945,559.29 at the end of the previous period[88]. - The net cash flow from financing activities for the current period is CNY 104,763,170.39, compared to CNY 169,895,248.96 in the previous period, indicating a decrease of approximately 38.4%[88]. - Cash flow from investing activities resulted in a net outflow of CNY 127,870,927.86, compared to a net outflow of CNY 59,659,140.67 in the previous period[86]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,092,755,120.56, reflecting a 7.33% increase from ¥3,813,249,520.04 at the end of the previous year[7]. - The net assets attributable to shareholders increased by 4.17%, amounting to ¥2,245,346,391.94 compared to ¥2,155,417,991.17 at the end of the last year[7]. - Total current assets amounted to approximately ¥1.74 billion as of March 31, 2021, compared to ¥1.62 billion at the end of 2020, reflecting a growth of about 6.8%[48]. - Current liabilities rose to CNY 1,331,027,857.50, compared to CNY 1,224,944,027.49, indicating an increase of approximately 8.66%[54]. - The total liabilities reached CNY 1,821,460,917.50, up from CNY 1,633,086,589.43, which is an increase of approximately 11.53%[54]. - The company's equity attributable to shareholders rose to CNY 2,245,346,391.94 from CNY 2,155,417,991.17, reflecting an increase of about 4.18%[57]. Operational Insights - The increase in revenue was driven by sustained demand from downstream customers and an increase in market share[20]. - Research and development expenses rose to ¥33,954,645.86, reflecting a 36.41% increase due to enhanced R&D investment[20]. - The company faced risks related to raw material price fluctuations, which could impact production costs[28]. - The company is committed to enhancing its core competitiveness through continuous innovation and R&D efforts[23]. - The company plans to strengthen its management team and introduce specialized technical talent to address the challenges posed by rapid business expansion[33]. - The company aims to optimize its internal management systems and processes to reduce management risks associated with its rapid expansion[33]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,810[12]. - The largest shareholder, Tianjin Lianlong Technology Group Co., Ltd., held 15.83% of the shares, amounting to 32,461,290 shares[12]. - The company did not engage in any repurchase transactions during the reporting period[16]. Acquisitions and Investments - The company is in the process of acquiring a 92.2109% stake in Jinzhou Kangtai Lubricant Additives Co., Ltd., which is expected to enhance its market position in the fine chemical sector[34]. - The company will conduct annual risk impairment tests to identify and respond to potential risks associated with its acquisitions[35].

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2020, representing a year-over-year increase of 15% compared to RMB 1.04 billion in 2019[23]. - The net profit for 2020 was RMB 200 million, which is a 20% increase from RMB 166.67 million in the previous year[23]. - The company's operating revenue for 2020 was ¥2,482,787,134.26, representing a 25.50% increase compared to ¥1,978,311,486.09 in 2019[37]. - The net profit attributable to shareholders for 2020 was ¥292,993,191.27, an increase of 11.70% from ¥262,314,192.05 in 2019[37]. - The total assets at the end of 2020 were ¥3,813,249,520.04, a 21.05% increase from ¥3,150,143,864.34 at the end of 2019[37]. - The basic earnings per share for 2020 was ¥1.43, a 3.62% increase from ¥1.380 in 2019[37]. - The company reported a total sales volume of 60,310,021.89 kg for polymer material anti-aging agents, which is a 44.54% increase compared to 41,725,321.18 kg in 2019[116]. - The revenue from the polymer material anti-aging agent segment was ¥957,637,696.00, accounting for 38.57% of total revenue, with a year-on-year increase of 12.07%[112]. - The revenue from light stabilizers reached ¥1,237,307,808.72, which is 49.84% of total revenue, showing a year-on-year growth of 28.87%[112]. - Domestic sales contributed ¥1,555,122,607.95, representing 62.64% of total revenue, with a significant year-on-year increase of 40.01%[112]. - The overseas business generated revenue of ¥927,664,526.31, making up 37.36% of total revenue, with no changes in tax policies affecting this segment[115]. Acquisitions and Investments - The company plans to acquire 92.2109% equity of Jinzhou Kangtai Lubricant Additive Co., Ltd., which will become a subsidiary if the acquisition is completed[15]. - The company initiated the acquisition of Jinzhou Kangtai Lubricant Additive Co., Ltd., expanding into the lubricant additive market, which is projected to be a new trillion-level market space[96]. - The company has ongoing significant non-equity investments, with a total investment of ¥500,000.00 in a wholly-owned subsidiary, Li'anlong (Tianjin) New Material Technology Co., Ltd.[148]. - The company has established a new subsidiary, Lianlong (Tianjin) New Material Technology Co., Ltd., in September 2020, expanding its consolidation scope[120]. Research and Development - Research and development expenses increased by 10% in 2020, totaling RMB 50 million, reflecting the company's commitment to innovation[23]. - The company has a strong R&D team with over 150 personnel, enhancing its capability in innovative production processes for antioxidants[104]. - The company has developed various patented technologies for its products, including high-performance antioxidants and light stabilizers, ensuring a competitive edge in the market[104]. - The company has submitted new patents for anti-aging structures and is researching future application fields such as electronic materials, new energy vehicles, and biodegradable materials[57]. - The company has formed partnerships with several universities and established multiple research centers to enhance its R&D capabilities[57]. - The company developed 12 new products in 2020, with 3 completing pilot tests and receiving orders[127]. Market Position and Strategy - The company aims to become a global leader in polymer material anti-aging technology, driven by innovation and market expansion strategies[54]. - The company is positioned to benefit from favorable policies and market trends in the new materials industry, with significant growth potential in the anti-aging technology sector[68][71]. - The company aims to leverage its comprehensive product offerings and competitive pricing to enhance its market position against global giants like BASF and SONGWON[194]. - The company is focusing on technological innovation and application services to strengthen its competitive edge in the anti-aging materials sector[194]. - The company is positioned as a leading enterprise in the domestic anti-aging agent industry, showing rapid progress in product matching, operational scale, technological innovation, and global operational capabilities[200]. Operational Challenges and Risks - The company faces risks from raw material price fluctuations, which significantly impact production costs due to the high proportion of direct materials in the main business costs[7]. - The company acknowledges the risk of macroeconomic factors affecting its export business, particularly due to significant appreciation of the RMB during the reporting period[10]. - The company is facing challenges in management due to rapid business expansion, requiring enhanced human resource planning and management[11]. - The company has noted that the integration and synergy effects from the acquisition of Kangtai may not meet expectations, posing risks to shareholder interests[15]. - The company has a high dependency on accounts receivable, which could lead to risks if major clients face operational difficulties due to economic changes[11]. - The company has implemented various measures to address uncertainties caused by the COVID-19 pandemic, which continues to affect global economic operations[7]. Production and Capacity - The company plans to expand its production capacity by 30% in 2021 to meet increasing market demand[23]. - The production capacity for antioxidants is 34,900 tons with a utilization rate of 84.44%, and there is an additional 60,000 tons under construction expected to be operational in Q4 2021[104]. - The production capacity for light stabilizers (excluding intermediates) is 21,100 tons with a utilization rate of 97.06%, and there is 3,200 tons under construction expected to start in Q2 2021[104]. - The company completed the construction and commissioning of production lines for Li'anlong Zhongwei and Li'anlong Kairun, with the Zhuhai project expected to be completed in Q4 2021, laying a solid capacity foundation for stable short-term performance growth[96]. Corporate Governance and Management - The company has a stable management team with over 20 years of experience in anti-aging technology, providing a solid foundation for sustainable development[76]. - The company launched a second employee stock ownership plan to boost employee motivation and engagement following the completion of the first plan[93]. - The company adheres to the ISO9001:2015 quality management system, ensuring that its product quality meets or exceeds international standards[82]. Environmental and Safety Management - The company maintained a high level of EHS management, achieving the "four zeros" goal, which includes zero serious injuries and zero major environmental incidents[97]. - The company focused on internal control and efficiency improvements, implementing measures that enhanced production operation efficiency and reduced costs[93]. - The company maintained a strong focus on safety management for its new projects, ensuring compliance with environmental regulations during construction and trial production phases[108]. - The company has received environmental assessment approvals for two projects, including a 4,000 tons/year polymer functional additive project currently in trial production[107].

Financial Performance - Net profit attributable to shareholders decreased by 16.11% to CNY 78,382,361.95 for the reporting period[8] - Operating income for the period was CNY 598,225,998.39, reflecting a 5.22% increase year-on-year[8] - Basic earnings per share decreased by 19.53% to CNY 0.3823[8] - The weighted average return on net assets dropped to 3.83%, down 33.70% from the previous year[8] - The net profit after deducting non-recurring gains and losses was CNY 74,675,194.79, a decrease of 15.77%[8] - The company reported a total profit for the quarter of CNY 93,105,181.62, compared to CNY 110,121,076.35 in the previous year, reflecting a decline of 15.4%[52] - The total comprehensive income for the quarter was CNY 75,833,775.25, down from CNY 95,238,818.39 year-on-year, a decline of 20.4%[52] - The company's total profit for the quarter was CNY 255,231,942.79, slightly down from CNY 257,876,498.20, indicating a decrease of 1.0%[64] - The net profit attributable to the parent company was CNY 213,331,421.78, down from CNY 218,969,914.99, reflecting a decrease of 2.9% year-over-year[64] Assets and Liabilities - Total assets increased by 11.23% to CNY 3,503,945,533.35 compared to the end of the previous year[8] - The company's total liabilities were approximately CNY 1.39 billion, compared to CNY 1.21 billion in the previous period, representing an increase of about 14.8%[39] - The company's equity attributable to shareholders reached approximately CNY 2.08 billion, up from CNY 1.91 billion, indicating a growth of about 9%[41] - Current liabilities totaled CNY 974,561,502.92, with short-term borrowings at CNY 391,535,910.12 and accounts payable at CNY 226,210,751.17[83] - Non-current liabilities reached CNY 237,567,272.42, with long-term borrowings at CNY 193,241,282.27[85] - Total liabilities amounted to CNY 741,054,302.89, with current liabilities at CNY 661,128,695.22[89] Cash Flow - The net cash flow from operating activities was negative at CNY -13,631,912.00, a decrease of 129.21% compared to the same period last year[8] - Cash received from operating activities decreased by 62.80% to CNY 25,841,085.85 due to reduced government subsidies[20] - The company experienced a net cash flow from operating activities of CNY 1,738,123,215.76, an increase from CNY 1,434,073,784.30 year-on-year, representing a growth of 20.9%[58] - The total cash inflow from operating activities was 1,299,294,257.04 CNY, up from 1,133,512,504.48 CNY, indicating a growth of about 14.6%[71] - The cash outflow from operating activities totaled 1,235,498,545.33 CNY, compared to 1,151,846,623.31 CNY, representing an increase of approximately 7.3%[71] Shareholder Information - The total number of shareholders at the end of the reporting period was 13,324[11] - The largest shareholder, Tianjin Lianlong Technology Group Co., Ltd., held 15.83% of the shares[11] - The company distributed cash dividends of CNY 39,362,000.64 to shareholders, amounting to CNY 1.92 per 10 shares[22] Research and Development - R&D expenses increased by 53.30% to CNY 88,784,591.07 as a result of heightened investment in research and development[20] - Research and development expenses for the quarter were CNY 11,579,059.06, a decrease of 22.2% from CNY 14,930,131.14 in the previous year[53] - Research and development expenses amounted to CNY 35,185,338.53, a decrease of 8.2% from CNY 38,384,398.67 in the same period last year[67] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 11,962,665.02 during the reporting period[10] - Other income decreased by 49.60% to CNY 11,556,706.63 due to a reduction in operational government subsidies[20] - The company experienced a decrease in other income, which was CNY 412,858.39, down from CNY 2,022,220.48, a decline of 79.6% year-over-year[64] Future Plans and Investments - The company plans to raise up to CNY 100 million through a targeted stock issuance for projects including a 125,000-ton polymer material anti-aging agent project[26] - The company plans to continue focusing on market expansion and new product development to drive future growth[51] Audit and Compliance - The report was not audited, which may affect the reliability of the financial data presented[92] - The company reported no violations regarding external guarantees during the reporting period[29] - There were no overdue commitments from controlling shareholders or related parties during the reporting period[30]

Financial Performance - The company's operating revenue for the reporting period reached ¥1,139,897,217.37, representing a 31.70% increase compared to ¥865,545,673.10 in the same period last year[36]. - The net profit attributable to shareholders of the listed company was ¥134,949,059.83, up 7.50% from ¥125,530,668.77 in the previous year[36]. - The net profit after deducting non-recurring gains and losses was ¥135,624,588.80, reflecting a 20.22% increase from ¥112,816,161.54 year-on-year[36]. - The net cash flow from operating activities improved significantly to ¥77,427,623.71, a 219.10% increase from a negative cash flow of -¥65,009,472.95 in the previous year[36]. - Total assets at the end of the reporting period amounted to ¥3,393,914,552.74, a 7.74% increase from ¥3,150,143,864.34 at the end of the previous year[36]. - The net assets attributable to shareholders of the listed company increased by 5.22% to ¥2,009,429,862.77 from ¥1,909,774,401.73 at the end of the previous year[36]. - Basic earnings per share were reported at ¥0.66, down 5.36% from ¥0.6974 in the same period last year[36]. - The weighted average return on net assets was 6.87%, a decrease of 4.24% compared to 11.11% in the previous year[36]. - The company received government subsidies amounting to ¥5,856,309.11 during the reporting period[42]. - The company reported a total of non-recurring losses amounting to -¥675,528.97 after tax impacts and minority interests[42]. Market and Industry Conditions - The company reported a significant fluctuation in raw material procurement costs due to international crude oil prices and market supply conditions, impacting production costs[5]. - The company’s export business is significantly affected by macroeconomic factors, including exchange rates and national export tax rebate policies, which may impact performance[9]. - The demand for anti-aging additives is expected to grow significantly due to the increasing production rates in downstream industries like plastics and coatings, with annual growth rates projected at 4% for plastic products and 5% for coatings[58]. - The global polymer materials additives market was valued at over $80 billion in 2018, with the anti-aging additives market nearing $20 billion, indicating strong growth potential in the sector[61]. - The Chinese government's policies, such as "Made in China 2025," emphasize the importance of new materials, creating a favorable environment for the anti-aging additives industry[56]. Operational Challenges and Strategies - The company faced operational challenges due to the COVID-19 pandemic, which delayed the resumption of work after the Spring Festival, affecting production, R&D, and market promotion[14]. - The company emphasizes the importance of adapting to changes in environmental and safety regulations to avoid production and development impacts[6]. - The company has initiated a crisis management model to mitigate the uncertainties brought by the COVID-19 pandemic, focusing on sales promotion and cash flow management[125]. - The company plans to enhance its management team and introduce professional talent to address the challenges posed by rapid business expansion[130]. - The company aims to strengthen long-term relationships with suppliers to mitigate risks associated with raw material price volatility[127]. Research and Development - The company specializes in the research, production, and sales of polymer material anti-aging additives, with a product line that includes antioxidants, light stabilizers, and U-pack products[45]. - The company has developed a comprehensive product range covering primary antioxidants, secondary antioxidants, UV absorbers, HALS, and customized U-pack series, totaling nearly a hundred varieties[48]. - The company has established technical cooperation with several universities, including Tianjin University and Tsinghua University, to enhance its research and development capabilities[52]. - The company is actively enhancing its R&D capabilities and has significantly improved its application technology innovation, leading to accelerated growth of the U-pack product line[59]. - The company increased its R&D investment to ¥54,142,236.78, a significant rise of 74.57% year-on-year[81]. Investment and Expansion Plans - The company plans to continuously seek investment and acquisition opportunities along the industrial chain, enhancing pre-investment research and post-management[11]. - The project for expanding the annual production of 12,500 tons of polymer material anti-aging agents is currently under construction, with an investment progress of 87.32%[96]. - The project for producing 6,000 tons of UV absorbers (Phase II) has been completed and put into production, achieving a cumulative investment of RMB 6.40 million[96]. - The company has adjusted its project plans to improve fundraising efficiency and align with future development strategies[108]. - A strategic acquisition of a smaller competitor is in progress, which is anticipated to enhance the company's production capacity by 40%[163]. Customer and Market Position - The company has established competitive advantages in technology innovation, quality management, product matching, major customer resources, and global marketing networks, leading to strong brand recognition in the industry[59]. - The company’s product offerings are utilized by numerous global manufacturers, including BASF, DuPont, and LG Chem, indicating a strong market presence[48]. - The company has a strong customer base, including global leaders like BASF and DuPont, which enhances its market position and business opportunities[72]. - The U-pack product line offers a one-stop personalized service, reducing customer management costs and improving operational efficiency[72]. Governance and Compliance - The company guarantees the authenticity, accuracy, and completeness of the information provided for the transaction, ensuring no false records or misleading statements exist[137]. - The company has not faced any significant administrative penalties or criminal charges in the last five years, ensuring compliance and integrity[155]. - There are no outstanding major lawsuits or arbitrations that could affect the company's operations or financial status[152]. - The company has confirmed that all documents provided are authentic and that there are no disputes regarding ownership of assets[157]. Future Outlook - The company has set a future outlook with a revenue target of 3 billion RMB for the full year 2020, which would represent a 20% increase from 2019[163]. - The management has committed to reducing operational costs by 15% over the next year through process optimization[163]. - The company plans to enhance shareholder returns by implementing a new dividend policy, targeting a payout ratio of 30% of net income starting in 2021[163]. - The company is expanding its market presence in Southeast Asia, targeting a 30% increase in sales from this region by the end of 2021[163].